Evox Therapeutics has a total of 303 patents globally, out of which 70 have been granted. Of these 303 patents, more than 48% patents are active. Europe (EPO) is where Evox Therapeutics has filed the maximum number of patents, followed by United States of America and Japan. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of Evox Therapeutics.
Evox Therapeutics Founded in 2016 and based in Oxford, UK, Evox Therapeutics develops exosome-based biotherapeutics by harnessing the natural delivery capabilities of extracellular vesicles. Spun out from Oxford University and the Karolinska Institutet, the company focuses on treating severe diseases through proprietary exosome engineering, delivery, and manufacturing technologies.
Do read about some of the most popular patents of Evox Therapeutics which have been covered by us in this article and also you can find Evox Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Evox Therapeutics patent portfolio.
How many patents does Evox Therapeutics have?
Evox Therapeutics has a total of 303 patents globally. These patents belong to 32 unique patent families. Out of 303 patents, 144 patents are active.
How Many Patents did Evox Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Evox Therapeutics Applications Filed | Evox Therapeutics Patents Granted |
2025 | – | 2 |
2024 | 5 | 7 |
2023 | 7 | 13 |
2022 | 17 | 22 |
2021 | 34 | 12 |
2020 | 36 | 8 |
2019 | 55 | 2 |
2018 | 56 | 2 |
2017 | 77 | 2 |
2016 | 4 | – |
How many Evox Therapeutics patents are Alive/Dead?
Worldwide Patents

How Many Patents did Evox Therapeutics File in Different Countries?

Countries in which Evox Therapeutics Filed Patents
Country | Patents |
Europe (EPO) | 32 |
United States of America | 30 |
Japan | 29 |
United Kingdom | 25 |
China | 22 |
Singapore | 18 |
Hong Kong (S.A.R.) | 18 |
Canada | 17 |
Australia | 14 |
Korea (South) | 10 |
India | 9 |
Germany | 8 |
Mexico | 7 |
Brazil | 7 |
Austria | 5 |
South Africa | 4 |
Russia | 4 |
Israel | 3 |
Spain | 3 |
Denmark | 3 |
Portugal | 3 |
Italy | 2 |
Norway | 2 |
Saudi Arabia | 1 |
Where are Research Centres of Evox Therapeutics Patents Located?

10 Best Evox Therapeutics Patents
WO2018015535A1 is the most popular patent in the Evox Therapeutics portfolio. It has received 53 citations so far from companies like Janssen Biotech, and Geno Membrane.
Below is the list of 10 most cited patents of Evox Therapeutics:
Publication Number | Citation Count |
WO2018015535A1 | 53 |
WO2017203260A1 | 42 |
WO2019092145A1 | 20 |
WO2018153581A1 | 20 |
WO2018011191A1 | 19 |
WO2019081474A1 | 13 |
CN109689098A | 12 |
WO2019238626A1 | 11 |
WO2019155060A1 | 11 |
US20210069254A1 | 10 |
What Percentage of Evox Therapeutics US Patent Applications were Granted?
Evox Therapeutics (Excluding its subsidiaries) has filed 30 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 35.29%.
Below are the key stats of Evox Therapeutics patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Evox Therapeutics?
Law Firm | Total Applications | Success Rate |
Howson & Howson Llp | 20 | 66.67% |
Cooley Llp | 9 | 0.00% |
Evox Therapeutics (In-House Dept.) | 1 | 0% |
What are Evox Therapeutics key innovation segments?
What Technologies are Covered by Evox Therapeutics?

The chart below distributes patents filed by Evox Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Evox Therapeutics thinks it’s important to protect particular technological inventions.

R&D Focus: How has Evox Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Evox Therapeutics?